Concomitant administration of varicella vaccine with combined measles, mumps, and rubella vaccine in healthy children aged 12 to 24 months of age.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Asian Pacific Journal of Allergy and Immunology

• Publication date

  2002-06-01

• Fields of study

  Medicine

• Identifiers
  PMID 12403196
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reactogenicity and immunogenicity of a new combined measles-mumps-rubella vaccine: results of a multicentre trial. The Cooperative Group for the Study of MMR vaccines.

  2000cited by this paper
• Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.

  2000cited by this paper
• Immune response and vaccine efficacy.

  1999cited by this paper
• The duration and magnitude of influenza epidemics: A study of surveillance data from sentinel general practices in England, Wales and the Netherlands

  1999cited by this paper
• A cost benefit analysis of routine varicella vaccination in Spain.

  1999cited by this paper
• Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children.

  1999cited by this paper
• The value of varicella vaccination in healthy children: cost-benefit analysis of the situation in France.

  1999cited by this paper
• Varicella immunization practices and the factors that influence them.

  1999cited by this paper
• Comparative study of reactogenicity and immunogenicity of new and established measles, mumps and rubella vaccines in healthy children

  1998cited by this paper
• Safety and characterization of the immune response engendered by two combined measles, mumps and rubella vaccines.

  1998cited by this paper
• Reactions of pediatricians to the recommendation for universal varicella vaccination.

  1998cited by this paper
• Costs and benefits of routine varicella vaccination in German children.

  1996cited by this paper
• Safety and immunogenicity of a combined live attenuated measles, mumps, rubella, and varicella vaccine (MMR(II)V) in healthy children.

  1996cited by this paper
• Childhood vaccination against chickenpox: an analysis of benefits and costs.

  1994cited by this paper
• Cost-effectiveness of a routine varicella vaccination program for US children.

  1994cited by this paper
• Placebo-controlled trial of varicella vaccine given with or after measles-mumps-rubella vaccine.

  1989cited by this paper
• Fragmentation of scheduled visits and missed doses among infants receiving multiple injected vaccines

  1977cited by this paper

• Prevention of measles, mumps and rubella: 40 years of global experience with M-M-RII

  2021cites this paper
• Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis

  2020cites this paper
• Immunogenicity and safety of the combined vaccine for measles, mumps, and rubella isolated or combined with the varicella component administered at 3-month intervals: randomised study

  2019cites this paper
• Two-year antibody persistence in children vaccinated at 12–15 months with a measles-mumps-rubella virus vaccine without human serum albumin

  2017cites this paper
• Combination Measles-Mumps-Rubella-Varicella Vaccine in Healthy Children

  2015cites this paper
• Risk of febrile seizure after measles-mumps-rubella-varicella vaccine: A systematic review and meta-analysis.

  2015influential citation
• Assessing mumps outbreak risk in highly vaccinated populations using spatial seroprevalence data.

  2014cites this paper
• Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults.

  2014cites this paper
• Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine: an open-labeled, randomized trial in healthy Korean children

  2013cites this paper
• Primary Versus Secondary Failure After Varicella Vaccination: Implications for Interval Between 2 Doses

  2013cites this paper
• Adverse events following a third dose of measles, mumps, and rubella vaccine in a mumps outbreak.

  2012cites this paper
• Sixteen Years of Global Experience with the First Refrigerator-Stable Varicella Vaccine (Varilrix™)

  2012cites this paper
• Measles, Mumps, Rubella Vaccine (Priorix™ GSK-MMR)

  2012cites this paper
• Understanding and Determining the Etiology of Autism

  2010cites this paper
• Primary versus secondary failure following varicella vaccination: implications for interval between two doses-Literature review

  2010cites this paper
• POST-MARKETING SURVEILLANCE OF A LIVE-ATTENUATED VARICELLA (OKA-STRAIN) VACCINE IN THE PHILIPPINES

  2010cites this paper
• The immunological basis for immunization series: module 16: mumps

  2010cites this paper
• Live Attenuated Measles, Mumps, Rubella, and Varicella Zoster Virus Vaccine (Priorix-Tetra™)

  2008cites this paper
• Safety, reactogenicity and immunogenicity of the live attenuated combined measles, mumps and rubella vaccine containing the RIT 4385 mumps strain in healthy Singaporean children.

  2007cites this paper
• Safety and Immunogenicity of Early Vaccination with Two Doses of Tetravalent Measles-Mumps-Rubella-Varicella (MMRV) Vaccine in Healthy Children from 9 Months of Age

  2007cites this paper
• Immunogenicity and Safety of a Second Dose of Measles–Mumps–Rubella–Varicella Vaccine in Healthy Children Aged 5 to 6 Years

  2007cites this paper
• Review of the Varilrix™ varicella vaccine

  2005cites this paper
• Protective efficacy of a recombinant plague vaccine when co-administered with another sub-unit or live attenuated vaccine.

  2005cites this paper
• Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella.

  2003cites this paper
• Is fever suppression involved in the etiology of autism and neurodevelopmental disorders?

  2003cites this paper
• Vaccine Reports

  year unknowncites this paper